A case of hyperprolactinemia, probably induced by eletriptan

Julian Davis, Hakki Yilmaz, Mustafa Kaya, Mustafa Özbek, Tuncay Delibaşi

    Research output: Contribution to journalArticlepeer-review


    A 25-year-old woman with a severe migraine begins to use a migraine specific agent, eletriptan (40 mg/d). One month later, she had oligomenorrhea and galactorrhea. We ruled out all causes of hyperprolactinemia. To our knowledge, this is the first published postmarketing case report of eletriptan-induced hyperprolactinemia, presented as oligomenorrhea and galactorrhea in a patient. The Naranjo probability scale indicates a probable relationship between hyperprolactinemia and eletriptan therapy. ©2012 Dustri-Verlag Dr. K. Feistle.
    Original languageEnglish
    Pages (from-to)907-908
    Number of pages1
    JournalInternational Journal of Clinical Pharmacology and Therapeutics
    Issue number12
    Publication statusPublished - Dec 2012


    • Adverse affect
    • Eletriptan
    • Hyperprolactinemia
    • Medication


    Dive into the research topics of 'A case of hyperprolactinemia, probably induced by eletriptan'. Together they form a unique fingerprint.

    Cite this